Strides Arcolab shines on acquiring CNS divisions of Ranbaxy Laboratories

21 Sep 2015 Evaluate

Strides Arcolab is currently trading at Rs. 1185.30, up by 39.45 points or 3.44% from its previous closing of Rs. 1145.85 on the BSE.

The scrip opened at Rs. 1161.00 and has touched a high and low of Rs. 1191.50 and Rs. 1160.60 respectively. So far 33070 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1373.00 on 20-Aug-2015 and a 52 week low of Rs. 625.10 on 26-Sep-2014.

Last one week high and low of the scrip stood at Rs. 1196.00 and Rs. 1100.80 respectively. The current market cap of the company is Rs. 7047.75 crore.

The promoters holding in the company stood at 27.65 % while Institutions and Non-Institutions held 45.94 % and 26.41 % respectively.

Strides Arcolab and Sun Pharmaceutical Industries have entered into a definitive agreement related to erstwhile Ranbaxy’s ‘Solus’ and ‘Solus Care’ divisions operating in the central nervous system (CNS) segment in India. The agreement involves transfer of these two marketing divisions, along with employees to Strides for a consideration of Rs 165 crore.

As per IMS July 2015 MAT report, all the products of these two divisions together accounted for approximately Rs 92 crore in sales. During the divestment process, Sun Pharma was cognizant that the interests of its employees working in Solus and Solus Care divisions were not compromised.

The transaction is subject to approval from the Competition Commission of India and other customary closing conditions.

Strides Pharma Scien Share Price

860.30 -9.10 (-1.05%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×